Loading market ticker...
Source: Shutterstock
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn More
Indian equity benchmarks closed higher on Thursday, 9 July 2026, recovering from the previous session's sharp sell-off. The BSE Sensex rose 238.22 points, or 0.31 per cent, to settle at 76,741.82, while the NSE Nifty 50 advanced 80.75 points, or 0.34 per cent, to end at 23,962.80, just short of the 24,000 mark. The gains snapped a two-day losing streak driven by escalating tensions between the United States and Iran.
Buying in index heavyweights and reports of fresh foreign fund inflows underpinned the recovery, even as elevated crude oil prices and the onset of the June-quarter earnings season kept participants measured.
Sun Pharmaceutical Industries (NSE:SUNPHARMA) was the biggest contributor to the advance, climbing 2.78 per cent, followed by Bharti Airtel (NSE:BHARTIARTL) with a 2.49 per cent gain, Bajaj Finserv (NSE:BAJAJFINSV) up 2.38 per cent, InterGlobe Aviation (NSE:INDIGO) up 2.08 per cent and Eternal (NSE:ETERNAL) up 2.01 per cent. On the losing side, Dr Reddy's Laboratories (NSE:DRREDDY) slumped 5.77 per cent after flagging a quality issue that delays commercial semaglutide supplies. Maruti Suzuki (NSE:MARUTI) fell 1.73 per cent, ONGC (NSE:ONGC) 1.42 per cent, Infosys (NSE:INFY) 1.31 per cent and NTPC (NSE:NTPC) 1.22 per cent.
Wednesday's session had seen a steep decline as fresh US military strikes on Iran and retaliatory attacks rattled global markets and pushed Brent crude sharply higher. Thursday brought bargain buying into stocks viewed as oversold, while short covering added pace to the recovery. Realty, media and PSU bank shares led the sectoral advance, and the broader market outperformed, with midcap and smallcap indices up 1.38 per cent and 1.8 per cent respectively.
The Q1 FY27 earnings season moved to centre stage, with Tata Consultancy Services (NSE:TCS) reporting results after Thursday's close and management commentary from IT majors expected to shape Friday's session. Crude oil remains the other swing factor: Brent had rallied more than 8 per cent over two sessions before adding another 1 per cent, keeping the rupee near a one-month low. Institutional flow data and the run-up to the SBI Funds Management IPO, opening 14 July, are also on the watchlist.
Thursday's rebound mirrored a tentative stabilisation in global risk appetite, with reports that Washington and Tehran were continuing technical-level talks despite the exchange of strikes. Overnight, US equities closed higher on strength in semiconductor stocks, and Asian markets carried that momentum into Friday morning, setting up expectations of a firm opening for Indian shares.
A 238-point Sensex gain restored some calm after two days of losses, but the drivers of volatility, crude oil, West Asia geopolitics and a heavy earnings calendar, remain fully in play. The Nifty's ability to reclaim and hold 24,000 is the near-term marker traders are watching.
Q: Why is the company in focus today?
A: The benchmark indices are in focus after snapping a two-day losing streak on 9 July 2026, with the Sensex up 238.22 points at 76,741.82 and the Nifty at 23,962.80. The rebound followed a sharp geopolitics-driven sell-off.
Q: What factors are investors monitoring?
A: Participants are tracking Q1 FY27 earnings beginning with TCS, crude oil prices amid the US-Iran conflict, rupee movements near a one-month low, and foreign institutional flows.
Q: Which peer companies are relevant?
A: Session leaders included Sun Pharma (NSE:SUNPHARMA), Bharti Airtel (NSE:BHARTIARTL) and Bajaj Finserv (NSE:BAJAJFINSV), while Dr Reddy's (NSE:DRREDDY) and Maruti Suzuki (NSE:MARUTI) were prominent losers. These moves framed the day's index action.
Q: Is this article investment advice?
A: No. This article is intended solely for informational purposes and should not be considered investment, financial or trading advice.
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
Copyright 2026 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.